These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

496 related items for PubMed ID: 11839683

  • 1. Protein kinase A RIalpha antisense inhibition of PC3M prostate cancer cell growth: Bcl-2 hyperphosphorylation, Bax up-regulation, and Bad-hypophosphorylation.
    Cho YS, Kim MK, Tan L, Srivastava R, Agrawal S, Cho-Chung YS.
    Clin Cancer Res; 2002 Feb; 8(2):607-14. PubMed ID: 11839683
    [Abstract] [Full Text] [Related]

  • 2. Antisense protein kinase A RIalpha acts synergistically with hydroxycamptothecin to inhibit growth and induce apoptosis in human cancer cells: molecular basis for combinatorial therapy.
    Cho YS, Cho-Chung YS.
    Clin Cancer Res; 2003 Mar; 9(3):1171-8. PubMed ID: 12631623
    [Abstract] [Full Text] [Related]

  • 3. Compensatory stabilization of RIIbeta protein, cell cycle deregulation, and growth arrest in colon and prostate carcinoma cells by antisense-directed down-regulation of protein kinase A RIalpha protein.
    Nesterova M, Noguchi K, Park YG, Lee YN, Cho-Chung YS.
    Clin Cancer Res; 2000 Sep; 6(9):3434-41. PubMed ID: 10999726
    [Abstract] [Full Text] [Related]

  • 4. CpG immunomer DNA enhances antisense protein kinase A RIalpha inhibition of multidrug-resistant colon carcinoma growth in nude mice: molecular basis for combinatorial therapy.
    Nesterova MV, Johnson NR, Stewart T, Abrams S, Cho-Chung YS.
    Clin Cancer Res; 2005 Aug 15; 11(16):5950-5. PubMed ID: 16115938
    [Abstract] [Full Text] [Related]

  • 5. Protein kinase A-Ialpha subunit-directed antisense inhibition of ovarian cancer cell growth: crosstalk with tyrosine kinase signaling pathway.
    Alper O, Hacker NF, Cho-Chung YS.
    Oncogene; 1999 Sep 02; 18(35):4999-5004. PubMed ID: 10490835
    [Abstract] [Full Text] [Related]

  • 6. Antisense protein kinase A RIalpha inhibits 7,12-dimethylbenz(a)anthracene-induction of mammary cancer: blockade at the initial phase of carcinogenesis.
    Nesterova MV, Cho-Chung YS.
    Clin Cancer Res; 2004 Jul 01; 10(13):4568-77. PubMed ID: 15240549
    [Abstract] [Full Text] [Related]

  • 7. Combined blockade of protein kinase A and bcl-2 by antisense strategy induces apoptosis and inhibits tumor growth and angiogenesis.
    Tortora G, Caputo R, Damiano V, Bianco R, Fontanini G, Cuccato S, De Placido S, Bianco AR, Ciardiello F.
    Clin Cancer Res; 2001 Aug 01; 7(8):2537-44. PubMed ID: 11489837
    [Abstract] [Full Text] [Related]

  • 8. Nuclear translocation of the catalytic subunit of protein kinase A induced by an antisense oligonucleotide directed against the RIalpha regulatory subunit.
    Neary CL, Cho-Chung YS.
    Oncogene; 2001 Nov 29; 20(55):8019-24. PubMed ID: 11753685
    [Abstract] [Full Text] [Related]

  • 9. Chemoprevention with protein kinase A RIalpha antisense in DMBA-mammary carcinogenesis.
    Nesterova MV, Cho-Chung YS.
    Ann N Y Acad Sci; 2005 Nov 29; 1058():255-64. PubMed ID: 16394142
    [Abstract] [Full Text] [Related]

  • 10. Extended survivability of prostate cancer cells in the absence of trophic factors: increased proliferation, evasion of apoptosis, and the role of apoptosis proteins.
    Tang DG, Li L, Chopra DP, Porter AT.
    Cancer Res; 1998 Aug 01; 58(15):3466-79. PubMed ID: 9699682
    [Abstract] [Full Text] [Related]

  • 11. Suppression of human prostate cancer cell growth by ciprofloxacin is associated with cell cycle arrest and apoptosis.
    Aranha O, Grignon R, Fernandes N, McDonnell TJ, Wood DP, Sarkar FH.
    Int J Oncol; 2003 Apr 01; 22(4):787-94. PubMed ID: 12632069
    [Abstract] [Full Text] [Related]

  • 12. Castration-induced up-regulation of insulin-like growth factor binding protein-5 potentiates insulin-like growth factor-I activity and accelerates progression to androgen independence in prostate cancer models.
    Miyake H, Pollak M, Gleave ME.
    Cancer Res; 2000 Jun 01; 60(11):3058-64. PubMed ID: 10850457
    [Abstract] [Full Text] [Related]

  • 13. Progression to androgen independence is delayed by adjuvant treatment with antisense Bcl-2 oligodeoxynucleotides after castration in the LNCaP prostate tumor model.
    Gleave M, Tolcher A, Miyake H, Nelson C, Brown B, Beraldi E, Goldie J.
    Clin Cancer Res; 1999 Oct 01; 5(10):2891-8. PubMed ID: 10537358
    [Abstract] [Full Text] [Related]

  • 14. Overexpression of BCL-X(L) underlies the molecular basis for resistance to staurosporine-induced apoptosis in PC-3 cells.
    Li X, Marani M, Mannucci R, Kinsey B, Andriani F, Nicoletti I, Denner L, Marcelli M.
    Cancer Res; 2001 Feb 15; 61(4):1699-706. PubMed ID: 11245486
    [Abstract] [Full Text] [Related]

  • 15. TabBO: a model reflecting common molecular features of androgen-independent prostate cancer.
    Navone NM, Rodriquez-Vargas MC, Benedict WF, Troncoso P, McDonnell TJ, Zhou JH, Luthra R, Logothetis CJ.
    Clin Cancer Res; 2000 Mar 15; 6(3):1190-7. PubMed ID: 10741751
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prostate-specific expression of Bax delivered by an adenoviral vector induces apoptosis in LNCaP prostate cancer cells.
    Lowe SL, Rubinchik S, Honda T, McDonnell TJ, Dong JY, Norris JS.
    Gene Ther; 2001 Sep 15; 8(18):1363-71. PubMed ID: 11571575
    [Abstract] [Full Text] [Related]

  • 18. Oligonucleotide sequence-specific inhibition of gene expression, tumor growth inhibition, and modulation of cAMP signaling by an RNA-DNA hybrid antisense targeted to protein kinase A RIalpha subunit.
    Nesterova M, Cho-Chung YS.
    Antisense Nucleic Acid Drug Dev; 2000 Dec 15; 10(6):423-33. PubMed ID: 11198926
    [Abstract] [Full Text] [Related]

  • 19. Id-1 expression promotes cell survival through activation of NF-kappaB signalling pathway in prostate cancer cells.
    Ling MT, Wang X, Ouyang XS, Xu K, Tsao SW, Wong YC.
    Oncogene; 2003 Jul 17; 22(29):4498-508. PubMed ID: 12881706
    [Abstract] [Full Text] [Related]

  • 20. Experimental gene therapy of human colon cancer.
    Bold RJ, Warren RE, Ishizuka J, Cho-Chung YS, Townsend CM, Thompson JC.
    Surgery; 1994 Aug 17; 116(2):189-95; discussion 195-6. PubMed ID: 8047985
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.